Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AstraZeneca
Company Monitoring Page for AstraZeneca
latest headlines for company on cafepharma
Big Pharma's Big Plans for New Fish Oil Drug
Motley Fool
Sat, 09/21/13 - 10:31 am
Tags:
Epanova
,
AstraZeneca
AstraZeneca, Bristol Recall Bydureon Diabetes Drug For Under-Filled Vials
WSJ Online
Fri, 09/20/13 - 10:20 am
Tags:
AstraZeneca
,
Bristol-Myers Squibb
,
Bydureon
,
diabetes
,
recalls
[video]What's Holding This Big Pharma Back?
Motley Fool
Wed, 09/18/13 - 12:42 pm
Tags:
AstraZeneca
Top 10 rheumatoid arthritis drugs 2013
Fierce Pharma
Wed, 09/18/13 - 10:27 am
Tags:
rheumatoid arthritis
,
Humira
,
AbbVie
,
Enbrel
,
Amgen
,
Remicade
,
Janssen
,
Celebrex
,
Pfizer
,
Bristol-Myers Squibb
,
Orencia
,
Cimza
,
UCB
,
Simponi
,
JNJ
,
Arthrotec
,
Vimovo
,
AstraZeneca
,
Kineret
AstraZeneca says FDA accepts application for Epanova
The Fly on the Wall
Wed, 09/18/13 - 08:46 am
Tags:
AstraZeneca
,
FDA
,
Epanova
,
hypertriglyceridemia
Repros Therapeutics: Winning The Battle But Losing The War?
Seeking Alpha
Tue, 09/17/13 - 09:34 am
Tags:
Repros Therapeutics
,
AstraZeneca
,
Sanofi
,
Androxal
,
testosterone
3 Things You Need to Know About This Big Pharma Deal
Motley Fool
Mon, 09/16/13 - 05:25 pm
Tags:
Merck
,
AstraZeneca
,
MK-1775
,
MK-3475
AstraZeneca pays $50 million for rights to Merck cancer drug
Yahoo/Reuters
Wed, 09/11/13 - 08:50 am
Tags:
Merck
,
AstraZeneca
,
ovarian cancer
,
MK-1775
AstraZeneca reverses $285 mln charge as cancer trial starts
Reuters
Wed, 09/4/13 - 09:19 am
Tags:
AstraZeneca
,
olaparib
,
ovarian cancer
AstraZeneca Reports Onglyza Data
Yahoo/Zacks
Wed, 09/4/13 - 08:57 am
Tags:
Onglyza
,
AstraZeneca
,
diabetes
Is 'No Worse Than Placebo' Good Enough For New Diabetes Drugs?
Forbes
Tue, 09/3/13 - 11:07 am
Tags:
diabetes
,
saxagliptin
,
alogliptin
,
AstraZeneca
,
Bristol-Myers Squibb
,
Takeda
Study finds patients often stop using new AstraZeneca heart drug
Reuters
Tue, 09/3/13 - 10:31 am
Tags:
Brilinta
,
AstraZeneca
3 PDUFA Dates That Will Kick Off 2014
Motley Fool
Tue, 08/27/13 - 05:34 pm
Tags:
FDA
,
diabetes
,
Forixga
,
Bristol-Myers Squibb
,
AstraZeneca
,
Biomarin
,
Vimizim
,
Amylin
,
metreleptin
AstraZeneca - Small Deal With Amplimmune Provides No Quick Fixes
Seeking Alpha
Tue, 08/27/13 - 09:09 am
Tags:
AstraZeneca
,
Amplimmune
,
M&A
AstraZeneca forges $500M cancer-combo tech buyout for MedImmune
Fierce Biotech
Mon, 08/26/13 - 09:34 am
Tags:
MedImmune
,
AstraZeneca
,
M&A
AstraZeneca to buy U.S. cancer firm for up to $500 mln
Reuters
Mon, 08/26/13 - 09:26 am
Tags:
AstraZeneca
,
M&A
,
Amplimmune
3 New Diabetes Drugs Possibly on the Way Soon
Motley Fool
Wed, 08/21/13 - 09:03 am
Tags:
diabetes
,
Forixga
,
AstraZeneca
,
Bristol-Myers Squibb
,
dulaglutide
,
Eli Lilly
,
Afrezza
,
MannKind
These drugs are the cash cows of big pharma
Quartz
Tue, 08/20/13 - 12:20 pm
Tags:
JNJ
,
Novartis
,
Pfizer
,
Merck
,
Roche
,
Bayer
,
Sanofi
,
GSK
,
Abbott Labs
,
AstraZeneca
,
Eli Lilly
How Much To Develop A Drug? An Update
Seeking Alpha
Mon, 08/12/13 - 11:51 am
Tags:
R&D
,
AstraZeneca
,
Bayer
,
Eli Lilly
,
Novartis
,
Pfizer
,
Regeneron
,
Roche
,
Shire
,
Takeda
Can AstraZeneca's New Strategy Save Its Stock?
Motley Fool
Sat, 08/10/13 - 12:25 pm
Tags:
AstraZeneca
Pages
« first
‹ previous
…
110
111
112
113
114
115
116
117
118
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.